15 Ankylosing Spondylitis Clinical Trials in Austin, MN (2026)

Q: How do I join a clinical trial in Austin?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you.

Recruiting Ankylosing Spondylitis Studies in Austin

NCT07318051Recruiting

Sample Collection for Ongoing Research and Product Evaluation Study

The SCORE study is a prospective, multi-site clinical trial designed to collect blood and tissue samples, along with relevant clinical data, from participants diagnosed with various solid tumors. The ...

Austin, MN9,600 participantsNatera, Inc.

View Study Details

NCT06226272Recruiting

Clinical Outcome Measure at Stryker Spine

This is a multicenter, prospective, retrospective, Post Market Clinical Follow-up (PMCF) study in subjects who have undergone or will undergo surgery utilizing one or more Stryker devices according to...

Austin, MN5,222 participantsVB Spine, LLC

View Study Details

NCT05458219Recruiting

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

This is a Phase Ia/Ib, multicenter, open-label, first-in-human study to evaluate the safety, tolerability, PK, and efficacy of IBI343 in participants with locally advanced unresectable or metastatic s...

Austin, MN470 participantsInnovent Biologics (Suzhou) Co. Ltd.

View Study Details

NCT07228026Recruiting

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

This study incorporates objectives directed at two subject cohorts: 1. Uncontrolled Adult and Pediatric Asthma Subjects: To demonstrate a statistically significant and clinically meaningful decline i...

Austin, MN160 participantsBiometry Inc

View Study Details

NCT07488676Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid tumors. GEJ is where the ...

Austin, MN150 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT06809400Recruiting

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

The purpose of this study is to generate evidence of the safety, tolerability, and pharmacokinetics/pharmacodynamics of IV LY4006896 compared with placebo in healthy participants and participants with...

Austin, MN127 participantsEli Lilly and Company

View Study Details

NCT06270706Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

This is a Phase 1a/1b, dose-escalation/expansion, consecutive-cohort, open-label study to evaluate the safety, tolerability, PK, PD, and preliminary evidence of antitumor activity of PLN-101095 in com...

Austin, MN124 participantsPliant Therapeutics, Inc.

View Study Details

NCT07408089Recruiting

Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

This is a first-in-human, open-label, Phase 1 study evaluating BBI-940, an investigational kinesin oral molecular degrader, administered as monotherapy or in combination with fulvestrant in adults wit...

Austin, MN96 participantsBoundless Bio, Inc.

View Study Details

NCT06585462Recruiting

Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses....

Austin, MN80 participantsAmgen

View Study Details

NCT07260253Recruiting

Remotely-supervised Neuromodulation in PPA

The goal of this clinical trial is to learn whether home-based brain stimulation combined with virtual speech-language therapy can improve communication abilities in adults with logopenic variant prim...

Austin, MN80 participantsMaya Henry

View Study Details

NCT06788912Recruiting

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

The main goals are after treatment given before surgery, to measure the number of people who have no signs of cancer cells in tumors and lymph nodes removed during surgery; and to learn about whether ...

Austin, MN60 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07391605Recruiting

Descartes-08 in Autoantibody Myositis

This is a randomized, double-blind, placebo-controlled phase 2 study to evaluate the efficacy, safety and tolerability of an autologous T-cells expressing a chimeric antigen receptor (CAR) directed to...

Austin, MN60 participantsCartesian Therapeutics

View Study Details

NCT07361861Recruiting

Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.

The purpose of this study is to determine whether hyperbaric oxygen therapy (HBOT) at 1.75 atmospheres of pressure (ATA) improves cardiovascular fitness (VO₂ max) and reduces inflammation in healthy a...

Austin, MN30 participantsUniversity of Texas at Austin

View Study Details

NCT06987539Recruiting

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

The primary objectives of this study are to characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of inebilizumab administered in pediatric participants with gMG, and to assess the safety a...

Austin, MN15 participantsAmgen

View Study Details

NCT06192576Recruiting

A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)

US, multicenter, cohort, open label observational study with primary data collection. Ancillary protocol-specified procedures to address the study objectives (eg, assessment of ADA) may be considered ...

Austin, MN10 participantsSanofi

View Study Details

About Ankylosing Spondylitis Clinical Trials in Austin

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 15 ankylosing spondylitis clinical trials recruiting participants in Austin, MN. These studies are seeking a combined 16,284 participants. Research is being sponsored by Natera, Inc., VB Spine, LLC, Innovent Biologics (Suzhou) Co. Ltd. and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Austin — FAQ

Are there ankylosing spondylitis clinical trials in Austin?

Yes, there are 15 ankylosing spondylitis clinical trials currently recruiting in Austin, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Austin?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you about next steps.

Are clinical trials in Austin free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Austin studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 15 active trials in Austin are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 13, 2026 from ClinicalTrials.gov